Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets.
- DOI
- 10.1016/j.medcli.2026.107574
- Published
- 2026-08-21
- Container
- Med Clin (Barc)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.medcli.2026.107574,
title = {Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets.},
author = {Castañeda-Pérez S and Ordieres-Ortega L and Alves-Pereira ED and Riera-Mestre A.},
year = {2026},
journal = {Med Clin (Barc)},
doi = {10.1016/j.medcli.2026.107574},
url = {https://doi.org/10.1016/j.medcli.2026.107574}
}RIS
TY - JOUR TI - Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets. AU - Castañeda-Pérez S AU - Ordieres-Ortega L AU - Alves-Pereira ED AU - Riera-Mestre A. PY - 2026 JO - Med Clin (Barc) DO - 10.1016/j.medcli.2026.107574 UR - https://doi.org/10.1016/j.medcli.2026.107574 ER -
APA
S, C., L, O., ED, A., & A., R. (2026). Systemic therapies in hereditary hemorrhagic telangiectasia: Current evidence and emerging targets.. Med Clin (Barc). https://doi.org/10.1016/j.medcli.2026.107574
Source records
- europe-pmc · retrieved 2026-09-27T02:25:03.647Z